Zobrazeno 1 - 10
of 55
pro vyhledávání: '"He Jun, Yuan"'
Publikováno v:
Journal of Medical Virology. 88:674-680
Occult hepatitis B infection (OBI), the presence of low hepatitis B virus (HBV) deoxyribonucleic acid (DNA) levels in patients without detectable hepatitis B surface antigen (HBsAg), has significant implications for understanding the natural history
Autor:
Mamta K. Jain, He Jun Yuan, Nahid Attar, Emmanuel Seremba, Reeti Joshi, Doan Dao, William M. Lee, Rafia Bhore
Publikováno v:
AIDS Patient Care and STDs. 26:73-80
Noninvasive markers of liver fibrosis, measured at baseline, have been shown to predict liver-related mortality. It remains unknown if a change in the value of the scores over time predicts mortality in patients with HIV and viral hepatitis. In this
Autor:
Linda S. Hynan, Jody Balko, Doan Y. Dao, Anna S.F. Lok, William M. Lee, He Jun Yuan, Corron Sanders, R. Ann Word, Nahid Attar
Publikováno v:
Hepatology. 55:676-684
Hepatitis B virus (HBV)-related acute liver failure (HBV-ALF) may occur after acute HBV infection (AHBV-ALF) or during an exacerbation of chronic HBV infection (CHBV-ALF). Clinical differentiation of the two is often difficult if a previous history o
Autor:
Nahid Attar, Beverley Adams-Huet, Mamta K. Jain, Janel Shelton, Michael Gale, He Jun Yuan, Song Zhang, Avidan U. Neumann, David S. Carney, Amanda Reeck, William M. Lee
Publikováno v:
The Journal of Infectious Diseases. 200:866-876
The combination of ribavirin and pegylated interferon is used to treat hepatitis C, but it achieves viral clearance in 19%–52% of patients infected with hepatitis C virus (HCV) genotype 1 and in 76%–80% of patients infected with HCV genotypes 2 a
Autor:
Man-Fung Yuen, Danny Ka-Ho Wong, Erwin Sablon, Ching-Lung Lai, He-Jun Yuan, Joke Doutreloigne
Publikováno v:
Journal of Infection. 54:497-503
Summary Objective To determine the prevalence of precore and core promoter (CP) mutations before, at and after HBeAg seroclearance in Chinese patients. Methods Precore and CP mutations were determined in 93 patients with chronic hepatitis B 12–24mo
Publikováno v:
Journal of medical virology. 88(4)
Occult hepatitis B infection (OBI), the presence of low hepatitis B virus (HBV) deoxyribonucleic acid (DNA) levels in patients without detectable hepatitis B surface antigen (HBsAg), has significant implications for understanding the natural history
Publikováno v:
Alimentary Pharmacology and Therapeutics. 22:301-307
Summary Background: The details of liver histology of patients with precore and core promoter mutations are still not clear. Aim: To determine the role of precore and core promoter mutations in liver histology in Chinese patients with chronic hepatit
Publikováno v:
Journal of Viral Hepatitis. 12:373-379
Summary. We studied the hepatitis B virus (HBV)-DNA levels below which the development of cirrhosis-related complications became unlikely in chronic hepatitis B (CHB). Seventy-nine Chinese CHB patients with cirrhosis-related complications and 158 age
Autor:
Simon Siu-Man Sum, Annie On-On Chan, John Chi-Hang Yuen, Man-Fung Yuen, Benjamin C.Y. Wong, Ching-Lung Lai, He-Jun Yuan, Danny Ka-Ho Wong
Publikováno v:
The American Journal of Gastroenterology. 100:1099-1103
To determine the effect of 1-yr lamivudine treatment on serum covalently closed-circular DNA (cccDNA) level.Serum total HBV DNA and cccDNA levels at baseline, week 24, and week 52 were measured in 82 lamivudine-treated patients, 17 of whom received 1
Autor:
Yasuhito Tanaka, Siu-Man Sum, Scott Fung, Danny Ka-Ho Wong, Man-Fung Yuen, John Chi-Hang Yuen, Annie On-On Chan, Masashi Mizokami, Ching-Lung Lai, He-Jun Yuan, Benjamin C.Y. Wong, Takanobu Kato
Publikováno v:
Journal of Clinical Microbiology. 42:5036-5040
The aims of this study were to compare chronic hepatitis B (CHB) patients with genotypes B and C for the probability of HBeAg seroconversion, hepatitis activity, and viral replication before and after HBeAg seroconversion and to compare the prevalenc